Sector: Pharmaceuticals & Biotechnology

Mid Cap

Procter & Gamble Health Share Price

Procter & Gamble Health Ltd.

₹5,698

145.00(2.61%)

Invest in PGHL with up to 3.33x margin.

Trade with MTF

25th May 2026 | 2:55 PM

NSE : PGHL

Open Free Demat Account

Procter & Gamble Health Performance

Price Movement

₹5698.00

₹5560.50

₹5741.00

↘ Today's Low↗ Today's High

1 Year Performance

₹5698.00

₹4707.00

₹6739.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹5,741.00

Low₹5,560.50

Open at₹5,649.00

Prev Close₹5,553.00

Volumes18.03 K

Avg Price₹5,645.34

Lower Circuit₹4,442.50

Upper Circuit₹6,663.50

Historical Performance

3M High₹5,420.00

3M Low₹4,707.00

1 Yr High₹6,739.00

1 Yr Low₹4,707.00

3 Yr High₹6,739.00

3 Yr Low₹4,636.55

5 Yr High₹6,739.00

5 Yr Low₹3,870.10

Procter & Gamble Health Fundamentals

Market Cap

Above industry Median

8,894 Cr.

PE Ratio (TTM)

Above industry Median

30.30

Dividend Yield

Market Runner Up

3.80

Net Profit TTM

24.1% incr over last year

293.49

Net Profit Growth

24.1% incr over last year

293.49

PEG Ratio

Above industry Median

1.30

ROE

16.9% incr over last year

43.65

Operating Revenue TTM

1,348.51

Operating Revenue Growth

16.3% incr over last year

Book Value

High in industry

12.80

MFI

MFI is mid-range

57.03

RSI

RSI is mid-range

60.33

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

12.80

Procter & Gamble Health Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	373.86	324.92	338.74	310.99	309.77
Operating Expense	263.40	204.65	248.40	230.07	186.34
Operating Profit	110.46	120.27	90.34	80.92	123.43
Depreciation	5.90	6.08	5.44	5.37	5.55
Interest	0.10	0.12	0.12	0.13	0.15
Tax	31.23	30.48	22.63	17.35	30.79
Net Profit	77.59	88.54	66.18	61.18	90.90

Procter & Gamble Health Technicals

Procter & Gamble Health Ltd. EMA & SMA

₹5698.00

357.50 (6.69%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹5283.6

Day EMA10 ₹5256.5

Day EMA12 ₹5245.4

Day EMA20 ₹5199.8

Day EMA26 ₹5171.8

Day EMA50 ₹5137.8

Day EMA100 ₹5239

Day EMA200 ₹5400.2

Procter & Gamble Health Support and Resistance

Resistance

First Resistance₹5397.00

Second Resistance₹5453.50

Third Resistance₹5542.00

Support

First Support₹5252.00

Second Support₹5163.50

Third Support₹5107.00

Technical Indicators

Day RSI60.33

Day MFI57.03

Day ADX30.02

Day Commodity Channel Index98.00

William-22.52

Day MACD73.57

Day MACD Signal Line72.02

Day ATR124.87

Day ROC125-8.78

Day ROC216.32

Procter & Gamble Health Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	51.8	51.8	51.8	51.8	51.8	51.8
FII	7	6.9	7	7.2	7	6.2
DII	14.7	14.2	14.1	13.9	13.8	13.7
Public	26.5	27.1	27	27	27.4	28.3

Procter & Gamble Health Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	27.14 K	30.39 K	89.31%
Week	10.32 K	15.16 K	68.07%
1 Month	9.93 K	16.1 K	61.66%
6 Month	9.1 K	14.32 K	63.56%

Procter & Gamble Health SWOT Analysis

Strengths15

Weakness5

Opportunity1

Threats1

MACD Crossover Above Signal Line

Companies with no Debt

Benjamin Graham Value Screen

Mid-range Performer (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Zero Promoter Pledge

RSI indicating price strength

MACD crossed above signal line previous end of day

Top Gainers

Procter & Gamble Health Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
12 Feb, 2026	50	SPECIAL	12 Feb, 2026	Equity Share
12 Feb, 2026	110	INTERIM	12 Feb, 2026	Equity Share
22 Aug, 2025	45	FINAL	22 Aug, 2025	Equity Share
21 Feb, 2025	80	INTERIM	21 Feb, 2025	Equity Share
28 Nov, 2024	60	FINAL		Equity Share
14 Feb, 2024	150	SPECIAL	14 Feb, 2024	Equity Share
14 Feb, 2024	50	INTERIM	14 Feb, 2024	Equity Share
23 Nov, 2023	50	FINAL		Equity Share
13 Feb, 2023	45	INTERIM	13 Feb, 2023	Equity Share
15 Nov, 2022	11.5	FINAL		Equity Share

Procter & Gamble Health Stock Comparison

Financials	Corona Remedies Ltd.	Rubicon Research Ltd.	Sanofi India Ltd.	Jeena Sikho Lifecare Ltd.	Senores Pharmaceuticals Ltd.
Price (₹)	₹1,700	₹944.95	₹3,186.80	₹633.75	₹1,148.50
% Change	0.91%	-0.51%	0.75%	-2.46%	3.38%
Revenue TTM (₹ Cr)	₹1,403.18	₹1,598.19	₹1,773.80	₹724.81	₹649.50
Net Profit TTM (₹ Cr)	₹185.12	₹206.20	₹309.80	₹204.17	₹115.38
PE TTM	57.20	78.90	23.70	39.60	43.30
1 Year Return	63.07	103.31	-49.13	62.44	111.14
ROCE	31.54	34.76	52.72	35.59	15.60

Similar Stocks

SANOFICONR

Sanofi Consumer Healthcare India Ltd.

₹ 4640.00

-2.01%

BLUEJET

Blue Jet Healthcare Ltd

₹ 481.10

+9.08%

CONCORDBIO

Concord Biotech Ltd.

₹ 1132.80

-1.78%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 729.90

+2.36%

SUPRIYA

Supriya Lifescience Ltd.

₹ 766.50

-0.98%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1051.90

+1.24%

COHANCE

Cohance Lifesciences Ltd.

₹ 433.70

+3.62%

ERIS

Eris Lifesciences Ltd.

₹ 1352.80

+0.67%

SYNGENE

Syngene International Ltd.

₹ 463.70

+0.40%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 229.25

+9.29%

STAR

Strides Pharma Science Ltd.

₹ 1191.30

+3.30%

GRANULES

Granules India Ltd.

₹ 758.90

+0.92%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 1005.60

-0.07%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2082.40

+2.68%

FAQ's on PGHL

What is the current share price of Procter & Gamble Health Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Procter & Gamble Health Ltd. is ₹ 5698 on the NSE and ₹ 5698.2 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Procter & Gamble Health Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Procter & Gamble Health Ltd. is approximately ₹ 8894 Cr.

What are the PE and PB ratios for Procter & Gamble Health Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Procter & Gamble Health Ltd. is 30.3, and the Price-to-Book (PB) ratio is 12.8.

What is the 52-Week High and Low for Procter & Gamble Health Ltd.?

Over the past 52 weeks, the highest price reached by Procter & Gamble Health Ltd. shares was ₹ 6739, and the lowest price was ₹ 4707.

What is the current dividend yield for Procter & Gamble Health Ltd.?

As of 6 June 2025, the dividend yield for Procter & Gamble Health Ltd. is 3.8%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Procter & Gamble Health Ltd.?

Significant shareholdings in Procter & Gamble Health Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Procter & Gamble Health Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Procter & Gamble Health Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Procter & Gamble Health Ltd.?

Procter & Gamble Health Ltd. last declared a SPECIAL dividend of ₹ 50 per share for the financial period ending 2026. The record date was set as 2026-02-12, and the payment was/is scheduled around 2026-02-12. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy